fluprednisolone has been researched along with Macular Edema in 10 studies
Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.
Macular Edema: Fluid accumulation in the outer layer of the MACULA LUTEA that results from intraocular or systemic insults. It may develop in a diffuse pattern where the macula appears thickened or it may acquire the characteristic petaloid appearance referred to as cystoid macular edema. Although macular edema may be associated with various underlying conditions, it is most commonly seen following intraocular surgery, venous occlusive disease, DIABETIC RETINOPATHY, and posterior segment inflammatory disease. (From Survey of Ophthalmology 2004; 49(5) 470-90)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe clinical outcomes associated with the use of topical difluprednate in treating uveitic cystoid macular edema." | 7.88 | Difluprednate for the Treatment of Uveitic Cystoid Macular Edema. ( Acharya, NR; Browne, EN; Chhetri, P; Niemeyer, KM; Schallhorn, JM, 2018) |
| "Twenty-seven patients (35 eyes) undergoing treatment with difluprednate 4 times daily for 3 weeks for noninfectious uveitic cystoid macular edema were reviewed for visual acuity, intraocular pressure, optical coherence tomography, and fluorescein angiography results." | 7.85 | RESOLUTION OF NONINFECTIOUS UVEITIC CYSTOID MACULAR EDEMA WITH TOPICAL DIFLUPREDNATE. ( Bena, J; Feiler, DL; Lowder, CY; Pichi, F; Srivastava, SK, 2017) |
| "To evaluate the efficacy and safety of treatment of diabetic macular edema (persistent type) with difluprednate ophthalmic emulsion 0." | 7.83 | Efficacy and safety of topical difluprednate in persistent diabetic macular edema. ( Kaur, S; Sachdev, N; Singh, S; Yangzes, S, 2016) |
| "To describe the use of topical difluprednate for the treatment of uveitic macular edema." | 7.83 | Topical difluprednate monotherapy for uveitic macular edema. ( Forooghian, F; Symes, RJ, 2016) |
| "To evaluate the clinical effect of topical difluprednate in pediatric patients for treatment of noninfectious uveitis." | 7.78 | Efficacy and potential complications of difluprednate use for pediatric uveitis. ( Herlihy, E; Ongchin, S; Slabaugh, MA; van Gelder, RN, 2012) |
| "To evaluate the efficacy of treatment of refractory diabetic macular edema (DME) after vitrectomy with difluprednate ophthalmic emulsion 0." | 7.76 | Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema. ( Abe, S; Kirii, E; Nakano, S; Yamamoto, T; Yamashita, H, 2010) |
| "To describe clinical outcomes associated with the use of topical difluprednate in treating uveitic cystoid macular edema." | 3.88 | Difluprednate for the Treatment of Uveitic Cystoid Macular Edema. ( Acharya, NR; Browne, EN; Chhetri, P; Niemeyer, KM; Schallhorn, JM, 2018) |
| "Twenty-seven patients (35 eyes) undergoing treatment with difluprednate 4 times daily for 3 weeks for noninfectious uveitic cystoid macular edema were reviewed for visual acuity, intraocular pressure, optical coherence tomography, and fluorescein angiography results." | 3.85 | RESOLUTION OF NONINFECTIOUS UVEITIC CYSTOID MACULAR EDEMA WITH TOPICAL DIFLUPREDNATE. ( Bena, J; Feiler, DL; Lowder, CY; Pichi, F; Srivastava, SK, 2017) |
| "To evaluate the efficacy and safety of treatment of diabetic macular edema (persistent type) with difluprednate ophthalmic emulsion 0." | 3.83 | Efficacy and safety of topical difluprednate in persistent diabetic macular edema. ( Kaur, S; Sachdev, N; Singh, S; Yangzes, S, 2016) |
| "To describe the use of topical difluprednate for the treatment of uveitic macular edema." | 3.83 | Topical difluprednate monotherapy for uveitic macular edema. ( Forooghian, F; Symes, RJ, 2016) |
| "To evaluate the clinical effect of topical difluprednate in pediatric patients for treatment of noninfectious uveitis." | 3.78 | Efficacy and potential complications of difluprednate use for pediatric uveitis. ( Herlihy, E; Ongchin, S; Slabaugh, MA; van Gelder, RN, 2012) |
| "To evaluate the efficacy of treatment of refractory diabetic macular edema (DME) after vitrectomy with difluprednate ophthalmic emulsion 0." | 3.76 | Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema. ( Abe, S; Kirii, E; Nakano, S; Yamamoto, T; Yamashita, H, 2010) |
| "Causes of panuveitis were considered and excluded based on a detailed history, physical examination, and laboratory investigations." | 1.33 | Conjunctival lymphoid hyperplasia presenting with bilateral panuveitis. ( Ioannidis, AS; Mulholland, B; Rai, P, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moshirfar, M | 1 |
| Somani, AN | 1 |
| Motlagh, MN | 1 |
| Ronquillo, YC | 1 |
| Schallhorn, JM | 1 |
| Niemeyer, KM | 1 |
| Browne, EN | 1 |
| Chhetri, P | 1 |
| Acharya, NR | 1 |
| Sathiamoorthi, S | 1 |
| Ruddy, KJ | 1 |
| Bakri, SJ | 1 |
| Kaur, S | 1 |
| Yangzes, S | 1 |
| Singh, S | 1 |
| Sachdev, N | 1 |
| Symes, RJ | 1 |
| Forooghian, F | 1 |
| Feiler, DL | 1 |
| Srivastava, SK | 1 |
| Pichi, F | 1 |
| Bena, J | 1 |
| Lowder, CY | 1 |
| Nakano, S | 1 |
| Yamamoto, T | 2 |
| Kirii, E | 2 |
| Abe, S | 2 |
| Yamashita, H | 2 |
| Nakano Goto, S | 1 |
| Slabaugh, MA | 1 |
| Herlihy, E | 1 |
| Ongchin, S | 1 |
| van Gelder, RN | 1 |
| Ioannidis, AS | 1 |
| Rai, P | 1 |
| Mulholland, B | 1 |
1 review available for fluprednisolone and Macular Edema
| Article | Year |
|---|---|
Management of cataract in the setting of uveitis: a review of the current literature.
Topics: Administration, Ophthalmic; Cataract; Cataract Extraction; Dexamethasone; Drug Implants; Flupredniso | 2020 |
9 other studies available for fluprednisolone and Macular Edema
| Article | Year |
|---|---|
Difluprednate for the Treatment of Uveitic Cystoid Macular Edema.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Fluprednisolone; Follow-Up Studies; Humans; M | 2018 |
Association of Uveitis and Macular Edema With Anastrozole Therapy.
Topics: Aged; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Lobular; Female; Fluorescein A | 2018 |
Efficacy and safety of topical difluprednate in persistent diabetic macular edema.
Topics: Aged; Diabetic Retinopathy; Female; Fluprednisolone; Follow-Up Studies; Glucocorticoids; Humans; Int | 2016 |
Topical difluprednate monotherapy for uveitic macular edema.
Topics: Administration, Topical; Adult; Female; Fluprednisolone; Glucocorticoids; Humans; Macular Edema; Mal | 2016 |
RESOLUTION OF NONINFECTIOUS UVEITIC CYSTOID MACULAR EDEMA WITH TOPICAL DIFLUPREDNATE.
Topics: Administration, Topical; Adult; Aged; Female; Fluorescein Angiography; Fluprednisolone; Glucocortico | 2017 |
Steroid eye drop treatment (difluprednate ophthalmic emulsion) is effective in reducing refractory diabetic macular edema.
Topics: Diabetic Retinopathy; Emulsions; Female; Fluprednisolone; Glucocorticoids; Humans; Injections; Macul | 2010 |
Treatment of diffuse diabetic macular oedema using steroid eye drops.
Topics: Aged; Blood Glucose; Case-Control Studies; Diabetic Retinopathy; Emulsions; Female; Fluprednisolone; | 2012 |
Efficacy and potential complications of difluprednate use for pediatric uveitis.
Topics: Administration, Topical; Adolescent; Aqueous Humor; Cataract; Child; Female; Fluprednisolone; Glucoc | 2012 |
Conjunctival lymphoid hyperplasia presenting with bilateral panuveitis.
Topics: B-Lymphocytes; Conjunctival Diseases; Drug Combinations; Female; Fluprednisolone; Glucocorticoids; H | 2005 |